Trials / Completed
CompletedNCT02518828
High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Alberta · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this pilot trial is to determine whether inpatients presenting to the Emergency Department (ED) with symptoms suggestive of Acute Heart Failure (AHF), who receive supplemental oxygen adjusted at either a high (SpO2 range ≥96%) or low (SpO2 range 90-92%) oxygen saturation level, leads to greater reduction in N-terminal-proBNP (NT-proBNP) at 72 hours.
Detailed description
Patients will be randomized to either a high (SpO2 range ≥96%) or low (SpO2 range 90-92%) oxygen after informed consent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High SpO2 | SpO2 range ≥96% |
| OTHER | Low SpO2 | SpO2 range 90-92% |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2015-08-10
- Last updated
- 2018-11-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02518828. Inclusion in this directory is not an endorsement.